Sydney Adventist Hospital, commonly known as the San, is a large private hospital in Sydney, Australia, located on Fox Valley Road in Wahroonga. Established on 1 January 1903, as a not-for-profit organisation, it was originally named the Sydney Sanitarium from which its colloquial name was derived.

There are 550 beds in Sydney Adventist Hospital.

During the past decade, Sydney Adventist Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 12 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sydney Adventist Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "University of Sydney" with 5 trials sponsored, "Biotronik SE & Co. KG" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sydney Adventist Hospital" #1 collaborator was "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 5 trials as a collaborator, "Astellas Pharma Inc" with 4 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 4 trials as a collaborator, "Cancer Trials Ireland" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Sydney Adventist Hospital" are "Prostate Cancer" (6 trials), "Breast Cancer" (2 trials), "Cancer of the Prostate" (2 trials), "Colorectal Cancer" (2 trials) and "Osteoarthritis" (2 trials). Many other conditions were trialed in "Sydney Adventist Hospital" in a lesser frequency.

Most popular intervention types in "Sydney Adventist Hospital" are "Drug" (28 trials), "Device" (8 trials), "Other" (4 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Enzalutamide" (6 trials), "Capecitabine" (2 trials), "DePuy Silent™ Hip femoral prosthesis" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sydney Adventist Hospital" are 30 trials for "All" genders, 11 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sydney Adventist Hospital". undefined are not yet recruiting, 11 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Sydney Adventist Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sydney Adventist Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 6 trials that are defined as “Not Applicable".

Sydney Adventist Hospital has several departments that took part in Clinical trials: "Sydney Adventist Hospital; Clinical Trial Unit" - 3 trials